Movement Disorders (revue) - Curation (Ncbi)

Index « Mesh.i » - entrée « Benserazide »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Benperidol < Benserazide < Benzamides  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000064 (1999) M C Prevett [Royaume-Uni] ; M N RossorCentral pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
000499 (2001) K P Datla [Royaume-Uni] ; S B Blunt ; D T DexterChronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
000524 (2001) E R Barbosa [Brésil] ; M D Leiros Da Costa ; L A Bacheschi ; M. Scaff ; C C LeiteParkinsonism after glycine-derivate exposure.
000927 (2002) Susan H. Fox [Royaume-Uni] ; Brian Henry ; Michael Hill ; Alan Crossman ; Jonathan BrotchieStimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
000C03 (2003) Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel ; Jörg Kazenwadel ; Thomas C. Wetter ; Wolfgang Oertel ; Roland Selzer ; Ralf KohnenOne-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
001183 (2005) Manuela Contin [Italie] ; Paolo Martinelli ; Mirella Mochi ; Roberto Riva ; Fiorenzo Albani ; Agostino BaruzziGenetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
001421 (2006) Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di PaoloPrevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
001459 (1992) M. Contin [Italie] ; R. Riva ; P. Martinelli ; A. BaruzziKinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease.
001705 (2006) Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen ; Jens Carsten Möller ; Claudia Trenkwalder ; Wolfgang H. OertelValidation of the "L-DOPA test" for diagnosis of restless legs syndrome.
001A54 (2007) Andrew H. Evans ; Helmut ButzkuevenDopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
001B33 (2007) Regina Katzenschlager [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; Kim Stockwell ; Kayhan A. Tayarani-Binazir ; Mohammed Zubair ; Lance A. Smith ; Peter Jenner ; Andrew J. LeesAntiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
002370 (2009) Victor S C. Fung [Australie] ; Lilie Herawati ; Ying WanQuality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
004586 (1988) G. Pezzoli [Italie] ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. ScarlatoMadopar HBS in fluctuating parkinsonian patients: two-year treatment.
004885 (1994) J M Olivé ; L. Masana ; J. GonzálezMeperidine and reversible parkinsonism.
004895 (1994) T. Klockgether [Allemagne] ; J. DichgansVisual control of arm movement in Parkinson's disease.
004956 (1993) P R Atchison [Royaume-Uni] ; P D Thompson ; R S Frackowiak ; C D MarsdenThe syndrome of gait ignition failure: a report of six cases.
004A12 (1993) G. Linazasoro [Espagne] ; J F Martí Mass ; J A SuárezNocturnal akathisia in Parkinson's disease: treatment with clozapine.
004C54 (1997) F. Lobbezoo [Canada] ; G J Lavigne ; R. Tanguay ; J Y MontplaisirThe effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial.
004D13 (1997) T. Hanihara [Japon] ; K. Inoue ; C. Kawanishi ; N. Sugiyama ; T. Miyakawa ; H. Onishi ; Y. Yamada ; H. Osaka ; K. Kosaka ; K. Iwabuchi ; M. Owada6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study.
004D37 (1997) J. Lyytinen [Finlande] ; S. Kaakkola ; S. Ahtila ; P. Tuomainen ; H. Ter V InenSimultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
004E65 (1998) P. Hagell [Suède] ; P. Odin ; E. VingePregnancy in Parkinson's disease: a review of the literature and a case report.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Benserazide" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Benserazide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Benserazide
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024